WELCOME TO THE SSBTR WEBSITE!

Students in leadership positions learn about brain tumors and gain real world experience in running a non-profit business while raising funds for brain tumor research. Beneficiaries of the money we raise are Barrow Neurological Institute, National Brain Tumor Society, Phoenix Childrens Hospital, Steele Childrens Research Center in Tucson, and Translational Genomics Research Institute (TGen). With your help we can make a difference. The intent of our website is to further our objectives of disseminating information about this disease process, stimulating more widespread involvement within our community through donating, volunteering and participating in one or more of our events, and publicizing and promoting this exceptional student-run organization.

"Be the change you wish to see in the world..." Gandhi

Thanks for visiting. Your support is greatly appreciated.

Upcoming Events

Videos


Philanthropic "Quotes"

  • “I shall pass through this world but once. Any good therefore that I can do or any kindness that I can show to any human being, let me do it now. Let me not defer or neglect it, for I shall not pass this way again.”

  • “I think the great livers, the people who are fully self-actualizing and alive, are the great givers.”

  • “You give but little when you give of your possessions. It is when you give of yourself that you truly give.”


RECENT BRAIN TUMOR ARTICLES

BLANK LINE

Brain Tumor News

  • Repurposing the old drug flavopiridol could be an effective strategy to cut short sugar availability and impair cancer growth.

  • Genetic tweaks to salmonella turn the bacteria into cancer-seeking missiles that produce self-destruct orders deep within tumors. Tests in rat models with extreme cases of the disease showed a remarkable 20 percent survival rate over 100 days -- roughly equivalent to 10 human years -- with the tumors going into complete remission.

  • Immunotherapy using genetically modified immune T-cells (CAR-T) to specifically target the glioma-associated marker IL13Rα2 — a gene expression indicative of an aggressive brain tumor — was reported to be a successful treatment for recurrent multifocal glioblastoma

  • New research out of the University of Michigan supports combining two approaches to fight back against gliomas: attacking the tumor with gene therapy while enhancing the immune system's ability to fight it, too.

  • Glioblastoma is the most common and most severe form of brain cancer. Of the 12,000 new cases diagnosed each year, 10,000 patients will die in about a year. But a new vaccine developed by researchers in Buffalo, New York, is showing promising results.

blank line

SSBTR in the News

© Copyright 2017